Return on Equity (ROE)
Updated 248h ago
Sector Performance
94th percentileEXPE
71.5%
Sector Median
13.8%
Sector Avg
31.4%
Deep Analysis
Return on Equity (ROE) measures how effectively a company generates profit from its shareholders' equity – the money invested by stockholders.
EXPE's current ROE of 71.5% is exceptionally high, meaning the company earned over 71 cents of profit for every dollar of equity in the most recent period. This compares to a sector median of 14.3%, placing EXPE in the 93rd percentile among its peers – far above the typical firm. Trend data is not available: the year-over-year change is N/A, the quarter-over-quarter change is N/A, and there is no historical series beyond the single 71.5% value. Without any trend, the combination of an extremely high level and no directional information implies that while the current profitability is strong, investors cannot assess whether it is stable, improving, or deteriorating, which adds uncertainty. This metric contradicts the overall
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about EXPE?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
Who are EXPE's closest peers by Return on Equity (ROE)?
The closest peers by Return on Equity (ROE) include: MRNA (-36.6%), FICO (-37.3%), XRAY (-37.7%), VRSN (-38.3%), MSCI (-45.3%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master EXPE's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full EXPE research report →EXPE
71.5%
Sector Median
13.8%
Sector Avg
31.4%
How EXPE's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.